优莎娜

优莎娜皇冠642系统核心成员网站,优莎娜运作需要注意的几个关键性问题!公爵QQ:793089571,电话:18859289892

导航

优莎娜并购拿牌企业葆婴 曲线获得中国直销牌照

优莎娜借助“曲线救国”策略,北美并购BabyCare(葆婴)公司,间接获取了中国政府发放的直销牌照。

目前,葆婴公司正在向优莎纳购买(质换)股份,预计本月下旬优莎纳美国年会,将会宣布与葆婴的合作消息,进而宣布间接获取到中国直销牌照的事情。

以下为公司网站新闻(英文翻译,不准确地方请包涵)

USANA(优莎娜)健康科学公司收购葆婴有限公司
Schedules Conference Call to Discuss This Announcement 附表电话会议来讨论这一公告

SALT LAKE CITY, Aug 16, 2010 (BUSINESS WIRE) --盐湖城,2010年8月16日(商业资讯) -

USANA Health Sciences, Inc. (NASDAQ: USNA) today announced that it has acquired BabyCare Ltd, a China-based direct selling company that develops, manufactures and sells nutritional products for the entire family, with an emphasis on infant nutrition. USANA健康科学公司(NASDAQ:USNA)今天宣布,它已经收购了葆婴有限公司,是一家中国的直销公司,开发生产和销售的整个家庭的营养产品,并重点对婴儿的营养。 Founded in 1999, privately held BabyCare Ltd is headquartered in Beijing, China, with operations in 21 cities and 16 provinces.成立于1999年,私人控股葆婴有限公司是总部设在北京,中国,其业务部门在21个城市和16个省。 BabyCare's products are sold through a growing distributor sales force, utilizing a commission-based compensation plan under a license to engage in direct selling activities in the Municipality of Beijing.葆婴的产品通过经销商销售人员越来越多,利用补偿计划下牌佣金从事市北京直销活动的研究。 BabyCare is working to obtain similar licenses in the other provinces in which it operates.葆婴正在努力获得它的运作类似的使用权,其中在其他省份。 This direct selling license allows BabyCare to engage non-employee distributors to sell BabyCare's products, apart from the company's traditional service centers.这种直接销售许可证允许葆婴从事非雇员经销商出售葆婴的产品,中心除了公司的传统服务。


Dave Wentz, USANA's chief executive officer, said, "We are very excited about this acquisition and the opportunity that it provides for USANA to ultimately establish a business via BabyCare in China. BabyCare is a natural fit for us, as they share our philosophy for high-quality products and pristine manufacturing practices. In fact, 15 of BabyCare's nutritional supplement products are qualified by SFDA, the Government's highest level of product regulatory approval. As a company with over 11 years of in-country experience, and as one of only 25 companies operating with a direct selling license in China, BabyCare brings us both valuable knowledge of China's direct selling market and the ability to expand our business in China via BabyCare. We believe this acquisition is the most effective way for us to enter this enormous market."戴夫温茨,USANA的首席执行官说:“我们非常葆婴兴奋,本次收购和机会,为它提供的USANA最终中国。建立经企业葆婴在对我们是一个自然的,因为他们分享我们的人生哲学高品质的产品和原始生产质量管理规范。事实上,产品15葆婴的营养补充品的审批合格由国家药监局,政府的规管最高水平的产品。作为一个经验的公司超过国家11年中,,和只有一个25家公司中国业务的销售牌照,将直接,婴儿为我们带来两销售市场的宝贵知识,中国的直接和能力,以扩大在葆婴中国通过我们的业务。我们相信此次收购是最有效的方式为我们进入这一巨大市场“。

USANA's objective for this acquisition in the short-term is to gain familiarity and expertise in the Chinese direct selling market. Usana的长远目标为,本次收购在短期内要取得直销市场的熟悉和专门知识中。 As such, during the next 18 to 24 months, BabyCare will continue to operate as a standalone business in China.因此,在未来18至24个月,婴儿将继续在中国作为一个独立的业务。 USANA believes that its direct selling expertise will assist BabyCare in generating incremental growth by reaching additional customers through an increased number of distributors selling their products.优莎娜认为,其直接销售的专业知识将帮助他们销售产品葆婴产生递增的增长,越来越多的分销商达成更多的顾客通过。 USANA's long-term objective for this acquisition, however, is to establish and grow the USANA brand throughout China. Usana的长期收购目标为这一点,然而,是建立和发展品牌在整个中国的USANA的。 In an effort to drive this long-term objective, USANA is already working to license some of its products to BabyCare to enhance BabyCare's product line.为了推动这一长期目标,工作的USANA已经授权其对某些产品,以提高葆婴葆婴的产品线。

The acquisition of BabyCare was accomplished by acquiring Pet Lane Inc., a Delaware corporation, who is the parent company of BabyCare in China. The transaction was entered into and closed according to the definitive terms of a share purchase agreement.的育婴收购是通过收购完成宠物巷公司是一家特拉华公司,谁是中国育婴公司的母公司。这项交易是进入封闭根据股份收购协议的最终条款1。 The purchase price for the shares consisted of $45 million in cash and 400,000 shares of USANA stock.该股份的购买价格为45美元包括现金和股票万USANA的400,000股。 The details of the transaction will be filed shortly in Forms 8-K.该交易的详情将于短期内提交表格8 - K表。

USANA's chief financial officer, Jeff Yates, said, "BabyCare provides USANA with an excellent entry point into this significant direct selling market. With 2009 annual net sales of approximately $15 million and total assets of $19 million, this operation provides a solid platform for future growth. Historically, BabyCare has not been profitable under its retail-based model, but is in the process of transitioning to operate under its direct selling license. Through BabyCare, residents of China, who have been interested in USANA, now have a significant opportunity to build a direct selling business in China. Considering this opportunity, coupled with BabyCare's established infrastructure, experienced management team and core customer base, we expect BabyCare's sales to increase much faster than they have historically." Usana的首席财政官杰夫耶茨说:“葆婴提供了市场的USANA(优莎娜)了一个良好的起点到这个重大的直接销售。随着2009年1900万的净销售额约为15百万元,总资产,这一行动提供了一个坚实的平台,为未来增长。历史,婴儿并未在其零售利润为基础的模式,但是转变的过程中是下经营其直销经营许可葆婴。通过,USANA的居民的中国,谁在被有兴趣,现在有一个重大的机遇建立在中国销售业务直接。考虑这个机会,加上育婴间的基础建设,经验丰富的管理团队和核心客户群,我们期待葆婴的销售额增加速度远远超过他们在历史上。“

Conference Call 电话会议

USANA will hold a conference call and webcast to discuss this announcement with investors on Tuesday, August 17, 2010 at 9:00 am Eastern Time. USANA将举行电话会议和网络会议,讨论这个投资者在周二公布的,2010年8月17日东部时间上午9:00。 Investors may listen to the call by dialing 877-941-2930 or accessing USANA's investor website at http://www.usanahealthsciences.com .投资者可收听电话会议通过拨打877-941-2930或访问的投资者网站的USANA http://www.usanahealthsciences.com

About USANA 关于优莎娜

USANA develops and manufactures high quality nutritional, personal care and weight management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands and the United Kingdom. USANA的开发和生产高品质的营养,体重管理及个人护理产品销往马来西亚直接联营公司墨西哥和首选的客户遍及美国,加拿大,澳大利亚,新西兰,香港,日本,台湾,韩国,新加坡, ,菲律宾,荷兰和英国。 More information on USANA can be found at http://www.usanahealthsciences.com . USANA的更多信息可在http://www.usanahealthsciences.com

Safe Harbor 安全港

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act.本新闻稿包含前瞻性陈述法在交易所的证券意义的第27A条的21è证券法和组。 Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion.我们的实际结果可能大不相同那些预期经济状况在这些前瞻性陈述,其中涉及一个数字全球风险和不确定性,包括一般,在我们的风险依赖网络的独立协会,在政府调控和市场营销我们的产品,制造,不利的宣传风险,风险与我们的国际扩张有关。 The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.本新闻稿中的内容,应考虑联同警告的危险因素,与交易委员会的警示性声明,并载于我们最近提交给证券与。 

SOURCE: USANA Health Sciences, Inc.消息来源:USANA健康科学公司

 

 

<< 优莎娜公爵调整脂肪肝餐单及案例优莎娜细胞式奖励计划(新修订),8.28日生效 >>

发表评论:

◎欢迎参与讨论,请在这里发表您的看法、交流您的观点。

最近发表

Powered By Z-Blog 1.8 Walle Build 91204 优莎娜 642系统 . Some Rights Reserved..闽ICP备09040012号.